Design and validation of a novel dosimetry phantom for motion management audits
Journal of Applied Clinical Medical Physics · 2025
DOI: 10.1002/acm2.70091 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Alex Burton und 5 weiteren Autor:innen. Beteiligte Einrichtung: Australian Clinical Dosimetry Service (ACDS), Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Yallambie, Victoria, Australia. Hauptthemen laut MEDLINE: Phantoms, Imaging, Radiotherapy Planning, Computer-Assisted, Film Dosimetry, Radiometry. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
We present a novel phantom design for conducting end‐to‐end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion‐included) and the dose delivered to the time‐averaged motion of the phantom (motion‐excluded) to be conducted simultaneously.
Purpose
To demonstrate the phantom's utility in a dosimetry audit and capacity to detect errors by quantifying spatial and dosimetric reproducibility.
Methods
Spatial and dosimetric reproducibility was quantified by repeat exposures using a simple lateral beam. Five exposures per measurement configuration were used. In each series of five measurements, the median film was used as the series reference to quantify the reproducibility of the remaining “test films.” Spatial reproducibility was quantified by comparing the position of isodose lines in two axes on the test films back to the series reference. Dosimetric reproducibility was quantified using gamma comparison between each test film and the series reference. Proof‐of‐concept of the motion‐excluded measurement capability was also established by comparing all films to treatment planning system (TPS) calculated dose distributions.
Results
Spatial reproducibility was better than 1 mm on all assessed metrics across all measurements. Film‐to‐film local gamma passing rates at 3%/0.6 mm were above 90% for all measurements. Film‐to‐TPS global gamma passing rates at 3%/1 mm were >95% in the motion‐excluded measurement series’, but
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian Clinical Dosimetry Service (ACDS), Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Yallambie, Victoria, Australia.
- Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- School of Science, RMIT University, Melbourne, Victoria, Australia.
- Centre for Medical Radiation Physics, University of Wollongong, wollongong, New South Wales, Australia.
Zitieren
APA
Burton, A., Beveridge, S., Hardcastle, N., Malfitana, S., Madamperuma, J., & Franich, R. (2025). Design and validation of a novel dosimetry phantom for motion management audits. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70091
Vancouver
Burton A, Beveridge S, Hardcastle N, Malfitana S, Madamperuma J, Franich R. Design and validation of a novel dosimetry phantom for motion management audits. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70091
BibTeX
@article{Burton2025,
author = {Burton, Alex and Beveridge, Sabeena and Hardcastle, Nicholas and Malfitana, Silvio and Madamperuma, Janaka and Franich, Rick},
title = {Design and validation of a novel dosimetry phantom for motion management audits},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
doi = {10.1002/acm2.70091}
}
EUVIMED